NCT06974578

Brief Summary

evaluate the clinical outcomes of routine CTR insertion in conjunction with hydrophilic versus hydrophobic IOLs following phacoemulsification.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 8, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

May 8, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 16, 2025

Completed
Last Updated

May 16, 2025

Status Verified

May 1, 2025

Enrollment Period

7 months

First QC Date

May 8, 2025

Last Update Submit

May 8, 2025

Conditions

Keywords

CTRIOLsPhacoemulsification

Outcome Measures

Primary Outcomes (2)

  • Change in BCVA (LogMAR)

    The formula: logMAR score (0.1 NL + 0.02 nl) where NL = number of lines completely read and nl = number of additional letters read ap- plies. For this method, the higher the logMAR VA score, the better the visual acuity.

    at 1, 3, and 6 months postoperatively.

  • Refractive error measurements (spherical equivalent)

    SE was calculated as the spherical power of the refractive error plus one-half of the cylinder power. Hyperopia was defined as a spherical equivalent (SE) values of ≥ + 1.00 diopter (D) and emmetropia as a SE ranging between 0.99 and - 0.49 D. Myopia was defined as a SE refraction of ≤ -0.50 D.

    at 1, 3, and 6 months postoperatively.

Study Arms (2)

Group A: CTR + Hydrophilic IOL

ACTIVE COMPARATOR

phacoemulsification and insertion of CTR the hydrophilic IOL

Procedure: phacoemulsificationDevice: CTRDevice: hydrophilic IOL

Group B: Hydrophobic IOL alone

ACTIVE COMPARATOR

phacoemulsification and insertiion of hydrophobic IOL

Procedure: phacoemulsificationDevice: Hydrophobic IOL

Interventions

cataract extracton with phacoemulsification

Group A: CTR + Hydrophilic IOLGroup B: Hydrophobic IOL alone
CTRDEVICE

insertion of capsualr tension ring

Group A: CTR + Hydrophilic IOL

implantation of hydrophilic IOL

Group A: CTR + Hydrophilic IOL

insertion of hydrophobic IOL

Group B: Hydrophobic IOL alone

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 40-80 years.
  • Visually significant cataract (≥3+ on Lens Opacities Classification System III "LOCSIII").
  • Clear cornea.

You may not qualify if:

  • Previous ocular surgery.
  • Zonular instability requiring CTR insertion beyond routine practice.
  • Complicated cataract cases (e.g., traumatic cataract).
  • Active intraocular inflammation or infection.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Al-Azhar Faculty of Medicine

Cairo, Egypt

Location

MeSH Terms

Interventions

Phacoemulsification

Intervention Hierarchy (Ancestors)

Cataract ExtractionRefractive Surgical ProceduresOphthalmologic Surgical ProceduresSurgical Procedures, OperativeUltrasonic Surgical Procedures

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

May 8, 2025

First Posted

May 16, 2025

Study Start

February 8, 2024

Primary Completion

September 1, 2024

Study Completion

September 1, 2024

Last Updated

May 16, 2025

Record last verified: 2025-05

Locations